T helper cells that produce IL-17 (TH17 cells) promote autoimmunity in mice and have been implicated in the pathogenesis of human inflammatory diseases. At mucosal surfaces, TH17 cells are thought to protect the host from infection, whereas regulatory T (Treg) cells control immune responses and inflammation triggered by the resident microflora1,2,3,4,5. Differentiation of both cell types requires transforming growth factor-β (TGF-β), but depends on distinct transcription factors: RORγt (encoded by Rorc(γt)) for TH17 cells and Foxp3 for Treg cells6,7,8. How TGF-β regulates the differentiation of T cells with opposing activities has been perplexing. Here we demonstrate that, together with pro-inflammatory cytokines, TGF-β orchestrates TH17 cell differentiation in a concentration-dependent manner. At low concentrations, TGF-β synergizes with interleukin (IL)-6 and IL-21 (refs 9–11) to promote IL-23 receptor (Il23r) expression, favouring TH17 cell differentiation. High concentrations of TGF-β repress IL23r expression and favour Foxp3+ Treg cells. RORγt and Foxp3 are co-expressed in naive CD4+ T cells exposed to TGF-β and in a subset of T cells in the small intestinal lamina propria of the mouse. In vitro, TGF-β-induced Foxp3 inhibits RORγt function, at least in part through their interaction. Accordingly, lamina propria T cells that co-express both transcription factors produce less IL-17 (also known as IL-17a) than those that express RORγt alone. IL-6, IL-21 and IL-23 relieve Foxp3-mediated inhibition of RORγt, thereby promoting TH17 cell differentiation. Therefore, the decision of antigen-stimulated cells to differentiate into either TH17 or Treg cells depends on the cytokine-regulated balance of RORγt and Foxp3.
When T lymphocytes are exposed to microbial antigens, they acquire diverse effector functions depending on which cytokines are produced by activated cells of the innate immune system12. Differentiation of pro-inflammatory TH17 cells requires the presence of IL-23, which is produced by activated dendritic cells13,14,15. In vitro, however, TH17 cell differentiation is independent of IL-23 and is induced by TGF-β plus IL-6 or IL-21 (refs 6, 9–11). Both in vitro and in vivo differentiation of the TH17 cell lineage require the upregulation of the orphan nuclear receptor RORγt7. TGF-β is also required to restrain inflammatory autoimmune responses16. Among its numerous properties is its ability to induce expression of Foxp3 in naive antigen-stimulated T cells, endowing the cells with regulatory or suppressor function8. Thus, TGF-β can induce both regulatory and pro-inflammatory T cells, depending on whether pro-inflammatory cytokines such as IL-6 and, potentially, IL-23 are present11,17. Treatment of antigen-receptor-stimulated T cells with TGF-β alone induces expression of both Foxp3 and RORγt, but not of IL-17 (refs 7, 11). After such treatment, a significant proportion of cells co-expressed the two transcription factors (Fig. 1a and Supplementary Fig. 1a). To determine whether co-expression also occurs in vivo, we examined CD4+ T cells from the small intestinal lamina propria of heterozygous RORγt–GFP (green fluorescent protein) knock-in mice, in which IL-17 is produced by TCR+GFPint lymphocytes7. Foxp3 was expressed in about 10% of sorted GFPint (RORγt+) cells (Fig. 1b and Supplementary Fig. 1b). In addition, Foxp3 was expressed in approximately 17–20% of GFP- lamina propria CD4+ T cells, consistent with the relatively large proportion of Treg cells in the intestine.
We next performed a fate-mapping analysis to determine the proportion of IL-17+ small intestinal T cells that had expressed Foxp3 during their ontogeny. Mice expressing Cre recombinase under the regulation of the Foxp3 locus (Y.P.R. et al., submitted) were crossed with Rosa26-stop–YFP reporter mice18, and female progeny (Rosa26stop–YFP/+; Foxp3cre/+) were analysed for expression of yellow fluorescent protein (YFP). When inactivation of X-linked Foxp3 was taken into account, we found that approximately 15% of IL-17- cells and 25% of IL-17+ cells had expressed Cre at some stage of development (Supplementary Fig. 2). The former represent Foxp3+ Treg cells, whereas the latter are the minimal proportion of TH17 cells that had expressed Foxp3 at some stage of their differentiation. These data suggest that Foxp3+ T cells can differentiate into TH17 cells in vivo in the presence of pro-inflammatory cytokines.
Examination of IL-17 expression in heterozygous RORγt–GFP knock-in mice revealed that RORγt+Foxp3+ lamina propria T cells produced much less IL-17 than RORγt+Foxp3- cells, suggesting that Foxp3 may interfere with the ability of RORγt to induce IL-17 (Fig. 1c). This is consistent with findings showing a >1,000-fold increase in Il17 messenger RNA, but little change in Rorc(γt), in Treg lineage cells that differentiate in the absence of Foxp3 (ref. 19). To investigate how Foxp3 may influence TH17 cell differentiation, we asked whether its induction would influence the expression of IL-17 in TGF-β-stimulated T cells. In naive T cells that had been transduced with a retroviral vector encoding RORγt, we found that, whereas IL-6 augmented the proportion of RORγt-IRES-GFP+ cells that expressed IL-17, TGF-β had a profound inhibitory effect even when added one day after transduction (Fig. 2a, b). Addition of TGF-β was followed by a sharp increase in expression of Foxp3 in the CD4+ T cells, and both the level of Foxp3 mRNA and proportion of Foxp3+ cells were not affected by the expression of RORγt (Fig. 2c).
To determine whether the inhibitory effect of TGF-β on RORγt is mediated by Foxp3, we knocked down expression of Foxp3 by using a short hairpin RNA (shRNA) vector. TGF-β-induced Foxp3 expression was reduced by the Foxp3-specific shRNA vector, but not by control hairpin vectors (Fig. 2c). Accordingly, TGF-β-mediated inhibition of RORγt-directed IL-17 expression was partially reversed by Foxp3 knockdown (Fig. 2d). Consistent with the idea that this inhibition was mediated by Foxp3 upregulation, the most pronounced rescue of IL-17 expression occurred in cells that had lost the most Foxp3 expression (Supplementary Fig. 3). Thus, Foxp3 induced by TGF-β inhibits the function of RORγt.
These results prompted us to ask whether Foxp3 interacts with RORγt to inhibit its function. Using a yeast two-hybrid screen, we previously found that human FOXP3 interacts with RAR-related orphan receptor A (RORA), and that an alternatively spliced isoform of FOXP3, lacking exon 2 (ref. 20), was deficient in this interaction21. We therefore examined whether mouse and human Foxp3 could similarly bind to RORγt, and whether such interaction was necessary for inhibition of the RORγt-mediated induction of IL-17. When Flag-epitope-tagged mouse Foxp3 was co-expressed with mouse RORγt in 293T cells, the two proteins were co-immunoprecipitated (Fig. 3a), even in the presence of DNase I or ethidium bromide, suggesting that the interaction does not involve DNA. A similar interaction was observed between human RORγT and FOXP3 (Fig. 3b). However, both mouse and human Foxp3 lacking the conserved exon 2-encoded sequence (Foxp3ΔEx2) had a substantially reduced association with RORγt (Fig. 3a, b). We examined the localization of the two proteins by confocal microscopy of HeLa cells transfected with Flag-tagged mouse Foxp3 constructs with or without mouse RORγt. Both Foxp3 and RORγt were localized in the nucleus, but Foxp3 lacking the DNA-binding forkhead domain (Foxp3ΔFKH) remained in the cytoplasm due to deletion of the nuclear localization signal in FKH22 (Supplementary Fig. 4). However, Foxp3ΔFKH translocated to the nucleus when it was co-expressed with RORγt, indicating that the Foxp3–RORγt interaction is independent of FKH. Accordingly, Foxp3ΔFKH co-immunoprecipitated with RORγt in extracts of transfected 293T cells (data not shown). A combined Foxp3ΔEx2/ΔFKH mutant remained in the cytoplasm even when it was co-expressed with RORγt, further indicating that Foxp3 interacts with RORγt by way of the exon 2-encoded sequence (Supplementary Fig. 4).
To investigate the role of the interaction between Foxp3 and RORγt in the repression of RORγt-induced transcription, we co-expressed these transcription factors in naive CD4+ T cells and examined expression of IL-17. Both mouse and human Foxp3 blocked RORγt-directed IL-17 expression, but full suppression required the presence of the exon 2-encoded sequence in Foxp3, suggesting that the interaction between Foxp3 and RORγt is essential (Fig. 3c and Supplementary Fig. 5). The ability of both mouse and human Foxp3 to repress RORγt-induced IL-17 expression was abrogated by deletion of the FKH domain or a point mutation in this domain (R397W) that impairs FOXP3 DNA-binding activity and was identified in X-linked immunodeficiency, polyendocrinopathy, enteropathy (IPEX) syndrome in humans23,24 (Fig. 3c and Supplementary Fig. 5). Therefore, Foxp3 can block the activity of RORγt at least in part through an interaction involving a sequence encoded by exon 2, but the requirement for an intact FKH domain suggests that its DNA-binding activity also contributes to inhibition of IL-17 expression. Thus, Foxp3 may inhibit RORγt-directed transcription through a mechanism similar to that proposed for its inhibition of IL-2 expression, involving its association with NFAT1 and Runx1 (refs 25 and 26). However, Foxp3ΔEx2 was as effective as the full-length protein in suppressing expression of IL-2 and interferon-γ (IFN-γ) in primary mouse T cells, indicating that, like the naturally occurring human spliced isoform20, it retains regulatory functions and can, presumably, associate with both NFAT1 and Runx1 (Supplementary Fig. 6).
Our results suggest that Foxp3 may inhibit RORγt activity on its target genes during TH17 cell differentiation. To extend our analysis from Il17 to other potential RORγt transcriptional targets, we examined the effect of TGF-β-induced Foxp3 on Il23r expression, which also requires the activity of RORγt10,11. Forced expression of wild-type mouse Foxp3 inhibited IL-6/IL-21-induced Il23r expression, whereas Foxp3ΔEx2 had less inhibitory activity (Fig. 4a); this is consistent with the notion that Foxp3 inhibits the function of RORγt through an interaction involving the sequence encoded by exon 2. Similar results were observed with Il22 expression in response to IL-6 or IL-21 (data not shown). Expression of Il22 and of Il23r in response to either IL-6 or forced expression of RORγt was also inhibited by high concentrations of TGF-β (refs 11, 27 and data not shown). However, at low concentrations, TGF-β synergized with IL-6 and IL-21 to enhance expression of Il23r mRNA (Fig. 4b). As a consequence, addition of IL-23 to cultures containing high concentrations of TGF-β had no effect on IL-17 expression, but significantly increased the number of IL-17+ cells and the level of IL-17 expression per cell when low concentrations of TGF-β were used (Figs 4c, d and Supplementary Fig. 7). In contrast, induction of Treg (Foxp3+) cells was optimal at high concentrations of TGF-β, but there was little induction at TGF-β concentrations at which IL-23 had a synergistic effect on expression of IL-17 (Fig. 4e).
TGF-β-induced Foxp3 expression is inhibited by IL-6 (ref. 17), IL-21 (ref. 10) and IL-23 (Supplementary Fig. 8). However, a substantial number of Foxp3+ cells differentiated in response to TGF-β, even in the presence of IL-6, and many of these cells also expressed IL-17 (Supplementary Fig. 9a). Conversely, many of the IL-17+ cells also expressed Foxp3. Thus, RORγt-dependent IL-17 expression can occur in the presence of Foxp3, but the level of Foxp3 may be insufficient to block RORγt function or, alternatively, IL-6 may overcome the inhibitory function of Foxp3. To examine this possibility, we added IL-6 or IL-21 to cultures of cells transduced with both RORγt and Foxp3. Under these conditions, the inhibitory effect of Foxp3 on IL-17 induction was largely circumvented, even though the level of Foxp3 protein was not affected (Supplementary Fig. 9b and data not shown); this suggests that IL-6 and IL-21 may have an additional post-translational effect on either Foxp3 or RORγt.
Our data collectively suggest that T cells receiving a TGF-β signal can acquire the potential to develop into either the Treg or the TH17 lineage. Foxp3 induction restrains the differentiation of inflammatory TH17 cells in response to TGF-β in the absence of other pro-inflammatory cytokines by inhibiting the activity of RORγt. In the presence of pro-inflammatory cytokines, the suppression of Foxp3 expression and inhibitory function, together with the concurrent upregulation or stabilization of RORγt expression, leads to full progression towards the TH17 lineage (Supplementary Fig. 10). This process may be especially relevant in the intestinal lamina propria, in which TGF-β can promote either TH17 or Treg cell lineage differentiation, depending on its local concentration. In this setting, a fine balance between RORγt and Foxp3 may be critical for immune homeostasis. In line with the observation that more Foxp3+ Treg cells were present in the gut of RORγt-deficient mice (Fig. 1b), these mutant mice were also protected from autoimmune disease (ref. 7 and data not shown). Conversely, a decrease of Foxp3 expression and function and an increase of RORγt expression tips the Treg/TH17 balance towards the TH17 cell lineage. This may occur in some autoimmune diseases, as suggested by the finding that an Il23r polymorphism correlates with protection from Crohn’s disease28. These results therefore have important implications for how peripheral tolerance is maintained in the presence of potentially pro-inflammatory cytokines.
C57BL/6 mice (Taconic), mice with a GFP reporter cDNA knocked in at the RORγt translation initiation site29, mice with an IRES-YFP-Cre cDNA knocked into the 3′ UTR of the Foxp3 locus (Y.P.R. et al., submitted) and Rosa26stop-YFP (ref. 18) mice were kept in specific pathogen-free (SPF) conditions at the animal facility of the Skirball Institute. All animal experiments were performed in accordance with approved protocols for the NYU Institutional Animal Care and Usage Committee.
Naive CD4+ T cells were purified and cultured as described previously7. In brief, 1.5 × 106 naive CD4+ T cells were cultured in wells of 24-well plates (or 0.7 × 106 cells per well in 48-well plates) containing plate-bound anti-CD3 (5 μg ml-1) and soluble anti-CD28 (1 μg ml-1). Cultures were supplemented with 2 μg ml-1 anti-IL-4 (BD Pharmingen), 2 μg ml-1 anti-IFN-γ (BD Pharmingen) with or without 80 U ml-1 human IL-2 (a gift from S. Reiner), 20 ng ml-1 IL-6 (eBioscience), 5 ng ml-1 TGF-β (PeproTech), 50 ng ml-1 IL-21 (R&D Systems) and 10 ng ml-1 IL-23 (eBioscience). Viral transduction was performed as described previously, unless indicated otherwise in the text7. T cells were isolated from the small intestinal lamina propria as described previously7.
All DNA constructs were generated by PCR-based methodology and confirmed by sequencing. Retroviral production and transduction were performed as described previously7. Protein–protein interaction was detected by co-immunoprecipitation and confocal microscopy in 293T cells and HeLa cells. Gene expression analysis was monitored by real-time PCR with reverse transcription (RT–PCR) using gene-specific primers and probes. IL-17 and Foxp3 protein expression were examined by intracellular staining performed according to the manufacturer’s protocol. Co-expression of RORγt and Foxp3 was examined by immunofluorescence using anti-RORγ30 and anti-Foxp3 antibodies.
Plasmids and retrovirus production
MIG, MIT and MCD2 are retrovirus-based vectors containing GFP, Thy1.1 and human CD2, respectively, under the regulation of an internal ribosome entry site (IRES). The Rorc(γt) cDNA was amplified by PCR and cloned into MIG (RORγt-IRES-GFP), MIT (RORγt-IRES-Thy1.1) and MCD2 (RORγt-IRES-hCD2). The wild-type full-length Foxp3 cDNA and various Foxp3 mutant cDNAs were amplified by PCR with a 5′ Flag-tagged primer and a 3′ corresponding primer, and were cloned into MIG (Foxp3-IRES-GFP). Il23r cDNA was PCR-amplified and cloned into MIG (IL-23R-IRES-GFP). Human FOXP3 cDNAs were PCR-amplified and cloned into MIG. MSCV-LTRmiR30-PIG (LMP) is a commercial vector from Openbiosystems. A double-stranded DNA oligonucleotide that targets the coding region of Foxp3 was cloned into LMP (LMP1066) according to the manufacturer’s protocol (the target sequence of Foxp3 is 5′-GGCAGAGGACACTCAATGAAAT-3′). Retrovirus production was as described previously7.
Surface and intracellular staining, and CFSE labelling
For intracellular staining, cells obtained from in vitro culture or isolated from the small intestinal lamina propria were incubated for 4–5 h with 50 ng ml-1 PMA (Sigma) and 500 ng ml-1 ionomycin (Sigma), plus 2 μg ml-1 Brefeldin A (Sigma) during the last 2 h. The cells were kept in a tissue-culture incubator at 37 °C. Surface staining was performed for 15–20 min with the corresponding cocktail of fluorescently labelled antibodies. After surface staining, the cells were resuspended in a Fixation/Permeabilization solution (BD Pharmingen), and intracellular cytokine staining was performed according to the manufacturer’s protocol. For intracellular staining of Foxp3, the Foxp3-Staining Buffer Set (fixation/permeabilization and permeabilization buffers) was used (eBioscience) according to the manufacturer’s protocol. For carboxyfluoroscein succinimidyl ester (CFSE)-labelling, sorted naive CD4+ T cells were washed twice with Hank’s Buffered Salt Solution (HBSS; Invitrogen), and labelled with 5 μM CFSE (Sigma) in HBSS for 10 min at 20 °C. The labelling was then stopped by adding 1/5 volume of FCS. The labelled cells were washed twice with the T cell culture medium before they were seeded and stimulated as described in the text.
Complementary DNA was synthesized and analysed by real-time quantitative PCR as described previously7. The starting quantity of the initial cDNA sample was calculated from primer-specific standard curves by using the iCycler Data Analysis Software. The expression level of each gene was normalized to the expression level of actin using the standard curve method. The primer sets and probes for real-time PCR were described elsewhere7,11.
Co-immunoprecipitation and western blot
Cells (293T cells) were transfected with the indicated constructs using Lipofectamine 2000 (Invitrogen). Forty-eight hours after transfection, whole-cell extracts were made in the lysis buffer, which contained 50 mM Tris-HCl (pH 8.0), 120 mM NaCl, 4 mM EDTA, 1% NP-40, 50 mM NaF, 1 mM Na3VO4 and protease inhibitors. After the insoluble material was removed by centrifugation, the lysate was immunoprecipated for 12–16 hours at 4 °C with anti-Flag M2 agarose beads (Sigma). After extensive washes with the lysis buffer, samples were resolved in an SDS–polyacrylamide gel electrophoresis (SDS–PAGE) gel and transferred to a nitrocellulose membrane. Western blotting was performed with an anti-Flag monoclonal antibody (Sigma), an anti-Foxp3 monoclonal antibody (eBioscience) and an anti-RORγt hamster monoclonal antibody30.
HeLa cells were plated on 8-well glass slides (Lab-Tek II Chamber Slide System) before transfection with the indicated constructs using Lipofectamine 2000 (Invitrogen). Forty-eight hours after transfection, cells were washed once in PBS, fixed for 15 min in 2% paraformaldehyde in phosphate buffer (PBS without saline), and then washed twice in PBS. Cells were blocked and permeabilized in PBS-XG (10% goat serum (Sigma) in PBS containing 0.1% Triton X-100) for 1 h at 20 °C. The cells were then incubated for 12–16 hours at 4 °C with anti-RORγt hybridoma supernatant30 (1:2 dilution in PBS-XG). After two washes in PBS, the cells were incubated for 1 h at room temperature with Cy3-conjugated goat anti-hamster antibody (Jackson ImmunoResearch Laboratory) at 1:400 dilution in PBS-XG. The cells were then washed three times in PBS and incubated for 1 h at 20 °C with anti-Flag M2 monoclonal antibody (Sigma) at 1:1,000 dilution in PBS-XG. After two washes in PBS, the cells were incubated for 1 h at 20 °C with anti-mouse Alexa 633 (Molecular Probes) at 1:200 dilution in PBS-XG. The cells were then washed twice in PBS and incubated for 5 min at 20 °C with 1 μg ml-1 DAPI (Sigma), washed two more times in PBS and mounted with Fluoromount-G (Southern Biotechnology Associates). The cells were examined with a Zeiss ZMD510 microscope with a CCD camera, and images were processed with Zeiss LSM Image Browser 4.0 and Adobe Photoshop 7.0.
Naive T cells were sorted as described previously and stimulated in the presence of the indicated cytokines as described7. Lamina propria lymphocytes from Rorc(γt)gfp/+ small intestines were isolated as described7, and CD4+GFPint and CD4+GFP- cells were sorted on a MoFlo cytometer (DAKO Cytomation). Naive T cells or sorted lamina propria T cells were then cytospinned on glass slides and fixed in 2% paraformaldehyde in phosphate buffer (PBS without saline) for 20 min at 20 °C. After blocking, immunofluorescence staining was performed by incubating the cells consecutively with the anti-RORγ antibody30 (hybridoma supernatant 1:4) for 12- 16 hours at 4 °C and biotin anti-mouse/rat Foxp3 monoclonal antibody (eBioscience clone FJK-16, 1:200 dilution) for 1.5 hours at 20 °C. The blocking solution contained PBS, 0.1% Triton-X100 and 10% goat serum. Secondary goat anti-Armenian-hamster Cy3 conjugated antibody (Jackson Immunoresearch) and streptavidin–APC (eBioscience), both at 1:400 dilution, were used at 20 °C for 1.5 hours to detect the RORγ and Foxp3 primary antibodies, respectively.
Weaver, C. T., Harrington, L. E., Mangan, P. R., Gavrieli, M. & Murphy, K. M. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24, 677–688 (2006)
Weaver, C. T., Hatton, R. D., Mangan, P. R. & Harrington, L. E. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25, 821–852 (2007)
McKenzie, B. S., Kastelein, R. A. & Cua, D. J. Understanding the IL-23–IL-17 immune pathway. Trends Immunol. 27, 17–23 (2006)
Lee, E. et al. Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J. Exp. Med. 199, 125–130 (2004)
Witowski, J., Ksiazek, K. & Jorres, A. Interleukin-17: a mediator of inflammatory responses. Cell. Mol. Life Sci. 61, 567–579 (2004)
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M. & Stockinger, B. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24, 179–189 (2006)
Ivanov, I. I. et al. The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126, 1121–1133 (2006)
Chen, W. et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198, 1875–1886 (2003)
Korn, T. et al. IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells. Nature 448, 484–487 (2007)
Nurieva, R. et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448, 480–483 (2007)
Zhou, L. et al. IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nature Immunol. 8, 967–974 (2007)
Murphy, K. M. & Reiner, S. L. The lineage decisions of helper T cells. Nature Rev. Immunol. 2, 933–944 (2002)
Langrish, C. L. et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201, 233–240 (2005)
Aggarwal, S., Ghilardi, N., Xie, M. H., de Sauvage, F. J. & Gurney, A. L. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278, 1910–1914 (2003)
Cua, D. J. et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421, 744–748 (2003)
Letterio, J. J. & Roberts, A. B. Regulation of immune responses by TGF-β. Annu. Rev. Immunol. 16, 137–161 (1998)
Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235–238 (2006)
Srinivas, S. et al. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev. Biol. 1, 4 (2001)
Gavin, M. A. et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445, 771–775 (2007)
Allan, S. E. et al. The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. J. Clin. Invest. 115, 3276–3284 (2005)
Du, J., Huang, C., Zhou, B. & Ziegler, S. F. Isoform-specfic inhibition of RORα-mediated transcriptional activation by human FOXP3. J. Immunol. (in the press)
Schubert, L. A., Jeffery, E., Zhang, Y., Ramsdell, F. & Ziegler, S. F. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J. Biol. Chem. 276, 37672–37679 (2001)
Wildin, R. S. et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nature Genet. 27, 18–20 (2001)
Lopes, J. E. et al. Analysis of FOXP3 reveals multiple domains required for its function as a transcriptional repressor. J. Immunol. 177, 3133–3142 (2006)
Ono, M. et al. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 446, 685–689 (2007)
Wu, Y. et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126, 375–387 (2006)
Zheng, Y. et al. Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445, 648–651 (2007)
Duerr, R. H. et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314, 1461–1463 (2006)
Eberl, G. et al. An essential function for the nuclear receptor RORγt in the generation of fetal lymphoid tissue inducer cells. Nature Immunol. 5, 64–73 (2004)
Sun, Z. et al. Requirement for RORγ in thymocyte survival and lymphoid organ development. Science 288, 2369–2373 (2000)
We thank P. Lopez and J. Hirst for assistance with cell sorting. We also thank J. Lafaille and D. Unutmaz for critical reading of the manuscript, and members of the Littman laboratory for their suggestions. L.Z., M.M.W.C. and I.I.I. were supported by fellowships from the Irvington Institute for Immunological Research, the Cancer Research Institute and the Crohn’s and Colitis Foundation of America, respectively. This work was supported by the Howard Hughes Medical Institute (D.R.L., A.Y.R.), the Sandler Program for Asthma Research (D.R.L.), the National Multiple Sclerosis Society (D.R.L.), the Helen and Martin Kimmel Center for Biology and Medicine (D.R.L.), NIH grant AI48779 (S.F.Z.), and the JDRF Collaborative Center for Cell Therapy (S.F.Z.).
Author Contributions L.Z., J.E.L., M.M.W.C, I.I.I. and Y.S. performed the experiments with assistance from R.M. and G.D.V. Y.P.R. and A.Y.R. provided mice for fate-mapping experiments. L.Z., S.F.Z. and D.R.L. designed the experiments, and L.Z. and D.R.L. wrote the manuscript with input from the co-authors.
About this article
Cite this article
Zhou, L., Lopes, J., Chong, M. et al. TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function. Nature 453, 236–240 (2008). https://doi.org/10.1038/nature06878
Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions
Signal Transduction and Targeted Therapy (2022)
Nature Reviews Cancer (2022)
Immune Inhibitory Properties and Therapeutic Prospects of Transforming Growth Factor-Beta and Interleukin 10 in Autoimmune Hepatitis
Digestive Diseases and Sciences (2022)
Clinical Reviews in Allergy & Immunology (2022)
Pathogenesis and management of gastrointestinal inflammation and fibrosis: from inflammatory bowel diseases to endoscopic surgery
Inflammation and Regeneration (2021)